To investigate the effect of the expanded CD14+HLA-DR+AXL+ subset on the impaired inflammatory cytokine responses observed in monocytes from patients with cirrhosis we assessed the functional properties of AXL+ monocytes ex vivo. This evidence concerns the gene CD14 and Cirrhosis.